Harold I Saavedra

Professor

Ponce Health Sciences University
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (5)

TNBC is most common in the NHB cohort. A, Stacked bar chart showing the fraction of patients with each level of HER2 expression among the four cohorts ( P = 0.387, χ 2 test). B, Stacked bar chart showing that the HR−/HER2− (triple-negative) phenotype is more frequent in the cores from the NHB patients ( P = 0.004, Fisher exact test). HR, hormone receptor (ER and PR); PPN, percent positive nuclei.

Year:

2025

High expression of the proliferative marker Ki-67 is more frequent among cores from the NHB cohort. A, Boxplots comparing Ki-67% positivity as a function of the cohort. B, Risk categories for Ki-67 (low risk, 14 PPN) are shown as stacked bar charts. Supplementary Table S13 tabulates these data (see rows Ki-67 PPN and Ki-67 risk category). PPN, percent positive nuclei.

Year:

2025

Breast cancer is a leading cause of cancer-related mortality among women worldwide and is known to have higher mortality among women with African ancestry. Herein, we describe the creation and characterization of a multiethnic breast cancer tissue microarray (ME-BrTMA) representing tumors from non-Hispanic White ( n = 41), non-Hispanic Black (NHB; n = 45), and Hispanic patients from Puerto Rico ( n = 36) and Florida ( n = 52). This ME-BrTMA comprises five blocks with a total of 610 cores: 371 breast cancer tumor cores, 93 breast stromal cores, 96 normal breast tissue cores, 30 non–breast cancer tumor cores, and 20 cores representing normal tissues. Initial characterization of the ME-BrTMA includes standard IHC staining of well-characterized clinical biomarkers, including the estrogen hormone receptors and progesterone hormone receptors, HER2, and Ki-67, interpreted by the coauthoring pathologist (Marilin Rosa). The IHC results indicated good but imperfect alignment with clinical diagnoses. Cores from breast cancer tumors from the NHB cohort most frequently scored negative for estrogen receptor (63%, P P P P Significance: The ME-BrTMA described herein provides a resource that may serve as a tool to understand the underlying biology of breast cancer.

Year:

2025

PAM50 analysis shows that basal-like subtype is most frequent among NHBs. Stacked bar chart shows the results of PAM50 gene expression analysis on patients represented on the ME-BrTMA with available RNA sequencing data. The data show that the basal-like subtype is most frequent among NHBs represented on the TMA ( P = 0.031). Supplementary Table S15 tabulates the PAM50 subgroup breakdown by cohort. Note that RNA sequencing data for the NHW patients in cohort 1 are not included because they are not available.

Year:

2025

The frequency of ER-negative and PR-negative expression is highest in tumor cores from patients in the NHB cohort. A, Stacked bar chart showing that the frequency of negative ER expression is highest in cores from the NHB cohort (Fisher exact test, P = 0.001). B, Stacked bar chart showing that the frequency of PR-negative expression is highest in cores from the NHB cohort (χ 2 test, P = 0.003). C, Stacked bar chart showing that the frequency of HR-negative expression is highest in cores from the NHB cohort (χ 2 test, P = 0.006, χ 2 test). PPN, percent positive nuclei.

Year:

2025

Collaborators (5)

Idhaliz Flores

Professor

Ponce Health Sciences University

UNITED STATES
View details

William D Cress

Senior Member

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES
View details

José Antonio Oliveras Torres

Assistant Professor / Puerto Rico BioBank Co-leader

Ponce Health Sciences University

UNITED STATES
View details

Steven Eschrich

Professor

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES
View details

Dung-Tsa Chen

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES
View details